Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Jubilant Pharma Ltd. and Aavis Pharmaceuticals launch Hydroxychloroquine Sulfate tablets in the U.S. market
Saturday, November 07, 2020Jubilant Pharma Ltd and Aavis Pharmaceuticals Inc announce the launch of Hydroxychloroquine Sulfate tablets mg a therapeutic equivalent version of Plaquenil hydroxychloroquine sulfate mg in the US market The product will be distributed by Jubilant...
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent
Friday, November 06, 2020Taysha Gene Therapies Inc a patientcentric gene therapy company focused on developing and commercializing adenoassociated virus AAVbased gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patie...
Isotopia Molecular Imaging begins clinical supply collaboration with Y-mAbs Therapeutics, Inc.
Friday, November 06, 2020Isotopia Molecular Imaging is pleased to announce that it has begun a collaboration with YmAbs Therapeutics Inc a latestage clinical biopharmaceutical company for the supply of the medical radioisotope nocarrieradded Lutetium to support clinical deve...
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Thursday, November 05, 2020Axsome Therapeutics Inc a biopharmaceutical company developing novel therapies for the management of central nervous system CNS disorders and Veeva Systems NYSE VEEV today announced a strategic partnership to augment the build of Axsomes DigitalCentr...
Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
Wednesday, November 04, 2020Humanigen Inc a clinical stage biopharmaceutical company focused on preventing and treating an immune hyperresponse called cytokine storm with its lead drug candidate lenzilumab announced the execution of its first licensing transaction in the AsiaP...
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
Wednesday, November 04, 2020TFF Pharmaceuticals Inc a clinicalstage biopharmaceutical company and Augmenta Bioworks Inc a biotechnology company enabling breakthroughs in medicine through immune profiling today jointly announce that both companies have entered into a worldwide J...
CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure
Tuesday, November 03, 2020CEPI the Coalition for Epidemic Preparedness Innovations announced that it will fund the development of the proteinbased STrimer COVID vaccine candidate by Sichuan Clover Biopharmaceuticals Inc China Clover through a global pivotal Phase efficacy cl...
Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes
Tuesday, November 03, 2020Zucara Therapeutics Inc a diabetes life sciences company developing the first oncedaily therapeutic to prevent insulininduced hypoglycemia low blood glucose levels today announced that it has expanded the development of ZT a somatostatin receptor an...
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
Monday, November 02, 2020Telix Pharmaceuticals Limited announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited China Grand Pharma for Telixs portfolio of MolecularlyTargeted Radiation MTR pr...
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
Saturday, October 31, 2020Ocular Therapeutix Inc a biopharmaceutical company focused on the formulation development and commercialization of innovative therapies for diseases and conditions of the eye today announced a license agreement and a collaboration with AffaMed Therap...
